Global Her2-Negative Breast Cancer Market 2015-2019

Bharat Book Bureau provides the report, on “Global HER2-Negative Breast Cancer Market 2015-2019”.https://www.bharatbook.com/healthcare-market-research-reports-714138/global-her2-negative-breast-cancer.html.These patients can be treated with chemotherapy or targeted therapy to improve their condition.

Oct 07 2015- Mumbai, India: Bharatbook.com announces a report on “Global HER2-Negative Breast Cancer Market 2015-2019”.The HER2 protein is found on the outer surface of the breast cells, and the hormone receptors are found inside breast cells.

About HER2-negative breast cancer

HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is expressed less in the tumor. https://www.bharatbook.com/healthcare-market-research-reports-714138/global-her2-negative-breast-cancer.html.According to the American Society of Clinical Oncology, most of the patients with breast cancer are known to have HER2-negative breast cancer. HER2-negative breast cancer patients can also be hormone receptor positive (HR+). The HER2 protein is found on the outer surface of the breast cells, and the hormone receptors are found inside breast cells. The cancers that have detectable hormone receptors are known as HR+ breast cancer, and those with HER2-negative have a low level of HER2 gene or the HER2 protein. HER2-negative breast cancer can also be HR+ and then the most preferred therapy is hormone therapy. These patients can be treated with chemotherapy or targeted therapy to improve their condition. It can also be treated with platinum-based drugs, and drugs such as capecitabine, eribulin, gemcitabine, ixabepilone, and vinorelbine. These drugs have several adverse effects on patients as some of them can attack the healthy cells of the body while destroying the malignant cells.

Technavio's analysts forecast the global HER2-negative breast cancer market to grow at a CAGR of 15.94% over the period 2014-2019.

Covered in this report

This report covers the...